Matrixx, Zicam Fail To Shut Down Cold Remedy MDL

Law360, New York (June 3, 2011, 5:30 PM EDT) -- An Arizona federal judge on Friday rejected arguments by Matrixx Initiatives Inc., Zicam LLC and others that the remaining plaintiffs in multidistrict litigation over Zicam Cold Remedy had not demonstrated the product could cause anosmia.

U.S. District Judge Frederick Martone denied the defendants' motion for summary judgment on the issue of general causation — whether the cold remedy had the capacity to cause a loss of the sense of smell. The defendants filed the motion in March, just months after Matrixx and Zicam agreed to pay...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.